Home/Filings/4/0000899243-23-009934
4//SEC Filing

Riefberg Vivian E. 4

Accession 0000899243-23-009934

CIK 0001828182other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 8:54 AM ET

Size

13.6 KB

Accession

0000899243-23-009934

Insider Transaction Report

Form 4
Period: 2023-03-29
Transactions
  • Conversion

    Class A Common Stock

    2023-03-29+24,17360,661 total
  • Disposition to Issuer

    Class A Common Stock

    2023-03-2914,67245,989 total
  • Disposition to Issuer

    Class A Common Stock

    2023-03-2945,9890 total
  • Conversion

    LLC Units in Cure Aggregator, LLC

    2023-03-2924,1730 total
    Class A Common Stock (24,173 underlying)
  • Disposition to Issuer

    Class B Common Stock

    2023-03-2924,1730 total
Footnotes (4)
  • [F1]On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), the Reporting Person received 24,173 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock.
  • [F2]Pursuant to the Merger Agreement, each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU.
  • [F3]Pursuant to the Merger Agreement, each share of Class B Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled.
  • [F4]Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration.

Issuer

Signify Health, Inc.

CIK 0001828182

Entity typeother

Related Parties

1
  • filerCIK 0001843139

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 8:54 AM ET
Size
13.6 KB